NeuroAllergy Research Laboratory (NARL), School of Life and Environmental Sciences, Deakin University, Waurn Ponds, VIC, Australia.
School of Medicine (Optometry), Deakin University, Waurn Ponds, VIC, Australia.
Front Immunol. 2024 May 24;15:1386344. doi: 10.3389/fimmu.2024.1386344. eCollection 2024.
Ocular allergy (OA) is a localized subset of allergy characterized by ocular surface itchiness, redness and inflammation. Inflammation and eye-rubbing, due to allergy-associated itch, are common in OA sufferers and may trigger changes to the ocular surface biochemistry. The primary aim of this study is to assess the differences in the human tear proteome between OA sufferers and Healthy Controls (HCs) across peak allergy season and off-peak season in Victoria, Australia.
19 participants (14 OA sufferers, 5 HCs) aged 18-45 were recruited for this study. Participants were grouped based on allergy symptom assessment questionnaire scoring. Proteins were extracted from human tear samples and were run on an Orbitrap Mass Spectrometer. Peaks were matched to a DIA library. Data was analyzed using the software MaxQuant, Perseus and IBM SPSS.
1267 proteins were identified in tear samples of OA sufferers and HCs. 23 proteins were differentially expressed between peak allergy season OA suffers vs HCs, and 21 were differentially expressed in off-peak season. Decreased proteins in OA sufferers related to cell structure regulation, inflammatory regulation and antimicrobial regulation. In both seasons, OA sufferers were shown to have increased expression of proteins relating to inflammation, immune responses and cellular development.
Tear protein identification showed dysregulation of proteins involved in inflammation, immunity and cellular structures. Proteins relating to cellular structure may suggest a possible link between OA-associated itch and the subsequent ocular surface damage via eye-rubbing, while inflammatory and immune protein changes highlight potential diagnostic and therapeutic biomarkers of OA.
眼部过敏(OA)是过敏的局部亚类,其特征为眼表面瘙痒、发红和炎症。过敏相关的瘙痒会导致炎症和揉眼,在 OA 患者中很常见,并且可能引发眼表面生物化学变化。本研究的主要目的是评估澳大利亚维多利亚州过敏高峰期和非高峰期 OA 患者与健康对照者(HCs)之间的人泪液蛋白质组的差异。
本研究招募了 19 名年龄在 18-45 岁之间的参与者(14 名 OA 患者,5 名 HCs)。根据过敏症状评估问卷评分对参与者进行分组。从人泪液样本中提取蛋白质,并在轨道阱质谱仪上运行。将峰与 DIA 文库匹配。使用 MaxQuant、Perseus 和 IBM SPSS 软件分析数据。
OA 患者和 HCs 的泪液样本中鉴定出 1267 种蛋白质。在过敏高峰期 OA 患者与 HCs 之间有 23 种蛋白质表达差异,在非高峰期有 21 种蛋白质表达差异。OA 患者中减少的蛋白质与细胞结构调节、炎症调节和抗菌调节有关。在两个季节中,OA 患者的炎症、免疫反应和细胞发育相关蛋白表达增加。
泪液蛋白鉴定显示与炎症、免疫和细胞结构相关的蛋白质失调。与细胞结构相关的蛋白质可能表明 OA 相关瘙痒与随后通过揉眼引起的眼表面损伤之间存在可能的联系,而炎症和免疫蛋白变化突出了 OA 的潜在诊断和治疗生物标志物。